|1.||Pari, Leelavinothan: 4 articles (03/2010 - 08/2006)|
|2.||Kukongviriyapan, Upa: 3 articles (01/2014 - 05/2011)|
|3.||Donpunha, Wanida: 3 articles (01/2014 - 05/2011)|
|4.||Kukongviriyapan, Veerapol: 3 articles (01/2014 - 05/2011)|
|5.||Pakdeechote, Poungrat: 3 articles (01/2014 - 05/2011)|
|6.||Phisalaphong, Chada: 3 articles (04/2012 - 01/2007)|
|7.||Murugan, Pidaran: 3 articles (10/2007 - 08/2006)|
|8.||Qiu, Feng: 2 articles (04/2015 - 05/2014)|
|9.||Changtam, Chatchawan: 2 articles (01/2015 - 04/2008)|
|10.||Patumraj, Suthiluk: 2 articles (01/2015 - 04/2008)|
|1.||Body Weight (Weight, Body)
03/01/2015 - "Tetrahydrocurcumin was orally administered every day at a dose of 80 mg/kg body weight for ten days, and a single dose of cisplatin was administered intraperitoneally (7.5 mg/kg body weight) in 0.9 % saline on day four. "
11/01/2006 - "Oral administration of tetrahydrocurcumin significantly prevented the occurrence of chloroquine (970 mg/kg body weight)-induced renal damage. "
08/01/2006 - "Tetrahydrocurcumin 80 mg/kg body weight was administered orally to diabetic rats for 45 days, resulted a significant reduction in blood glucose and significant increase in plasma insulin in diabetic rats, which proved its antidiabetic effect. "
03/01/2010 - "We have shown that separate dose of tetrahydrocurcumin (THC) at a dose of 80 mg/kg body weight (b.w.) and chlorogenic acid (CGA) at a dose of 5 mg/kg b.w. "
10/01/2007 - "Oral administration of tetrahydrocurcumin at 80 mg/kg body weight to diabetic rats for 45 days resulted in a significant reduction in blood glucose and significant increase in plasma insulin levels. "
03/01/2015 - "These results collectively provide therapeutic evidence that tetrahydrocurcumin ameliorates renal damage by regulating inflammation and apoptosis. "
03/01/2015 - "In the present study, we investigated the protective effect and mechanism of tetrahydrocurcumin on cisplatin-induced kidney damage, oxidative stress, and inflammation to evaluate its possible use in renal damage. "
07/01/2008 - "Curcumin can reduce inflammation and neurodegeneration, but its chemical instability and metabolism raise concerns, including whether the more stable metabolite tetrahydrocurcumin (TC) may mediate efficacy. "
|3.||Hypertension (High Blood Pressure)
01/01/2015 - "Correction: Tetrahydrocurcumin protects against cadmium-induced hypertension, raised arterial stiffness and vascular remodeling in mice."
01/01/2014 - "Tetrahydrocurcumin protects against cadmium-induced hypertension, raised arterial stiffness and vascular remodeling in mice."
04/01/2012 - "Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency."
05/01/2011 - "Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension."
|3.||Blood Glucose (Blood Sugar)
|4.||Cytochromes c (Cytochrome c)
|5.||NG-Nitroarginine Methyl Ester (L-NAME)
|10.||1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)